Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COAST – Cisplatin Ototoxicity Attenuated by Aspirin
2012-001509-25Phase 2Completed
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Aug 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of aspirin in ototoxicity and Hypoacusis (2 arms), sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: Change in hearing at 4–7 days post-treatment. Started Aug 2012; status: completed.
02
Drugs
aspirin
03
Conditions
ototoxicityHypoacusis
Beyond the preview
Go deeper on 2012-001509-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001509-25.